As a team of highly-trained, proactive and experienced regulatory writers from a variety of backgrounds, ClaritiDox currently provides writing services to over 25 pharmaceutical and biotechnology clients.  Our regulatory and disease-specific expertise is continuously expanding beyond our core foundations in oncology, respiratory disorders, cardiovascular disorders, central nervous system disorders, rare diseases, and novel treatment approaches (e.g., pediatric gene therapy).  With a commitment to excellence and a focus on open collaboration and generous knowledge sharing, we are eager to join and support teams who share our philosophy.